Clinical Trial Update: Mirtazapine for Sleep Disorders in Alzheimer's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating mirtazapine for sleep disorders in Alzheimer's disease; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Sleep Disorders

Drugs mentioned

• mirtazapine (mirtazapine)

Snippet

Sponsor: Brasilia University Hospital | Conditions: Alzheimer's Disease, Sleep Disorders | Phase 3 | Status: UNKNOWN